{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-23-003597","form_type":"8-K","ticker":"JSPR","cik":"0001788028","company_name":"Jasper Therapeutics, Inc.","filed_at":"2023-01-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:46.549991+00:00","generated_at":"2026-06-20T13:11:05.004020+00:00","sec_items":["8.01","9.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Jasper Therapeutics regains Nasdaq minimum bid price compliance","bullets":["Received Nasdaq letter on Jan 18, 2023 confirming full compliance with Listing Rule 5550(a)(2).","Closing bid price of voting common stock was $1.00 or higher for ten consecutive days (Jan 3-17, 2023).","Compliance removes risk of delisting from Nasdaq Capital Market."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-23-003597","json":"https://secwatch.observer/filing/0001213900-23-003597.json","markdown":"https://secwatch.observer/filing/0001213900-23-003597.md","text":"https://secwatch.observer/filing/0001213900-23-003597.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1788028/000121390023003597/0001213900-23-003597-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1788028/000121390023003597/ea171850-8k_jasper.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T13:11:05.004020+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}